Skayneh, H.; Jishi, B.; Hleihel, R.; Hamie, M.; El Hajj, R.; Deleuze-Masquefa, C.; Bonnet, P.-A.; El Sabban, M.; El Hajj, H.
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML. Int. J. Mol. Sci. 2022, 23, 3421.
https://doi.org/10.3390/ijms23073421
AMA Style
Skayneh H, Jishi B, Hleihel R, Hamie M, El Hajj R, Deleuze-Masquefa C, Bonnet P-A, El Sabban M, El Hajj H.
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML. International Journal of Molecular Sciences. 2022; 23(7):3421.
https://doi.org/10.3390/ijms23073421
Chicago/Turabian Style
Skayneh, Hala, Batoul Jishi, Rita Hleihel, Maguy Hamie, Rana El Hajj, Carine Deleuze-Masquefa, Pierre-Antoine Bonnet, Marwan El Sabban, and Hiba El Hajj.
2022. "EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML" International Journal of Molecular Sciences 23, no. 7: 3421.
https://doi.org/10.3390/ijms23073421
APA Style
Skayneh, H., Jishi, B., Hleihel, R., Hamie, M., El Hajj, R., Deleuze-Masquefa, C., Bonnet, P.-A., El Sabban, M., & El Hajj, H.
(2022). EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML. International Journal of Molecular Sciences, 23(7), 3421.
https://doi.org/10.3390/ijms23073421
